Last quarter (Q2 2022), Consun Pharmaceutical Group Ltd.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Consun Pharmaceutical Group Ltd.'s net income was $―. See Consun Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ ―	$ 2.04B	$ 1.75B	$ 1.73B	$ 1.84B	$ 1.66B
Cost of Revenue	$ ―	$ 517.32M	$ 431.16M	$ 466.85M	$ 459.55M	$ 431.83M
Gross Profit	$ ―	$ 1.53B	$ 1.32B	$ 1.26B	$ 1.38B	$ 1.23B
Operating Expense	$ ―	$ 875.02M	$ 767.88M	$ 693.85M	$ 730.15M	$ 695.27M
Operating Income	$ ―	$ 652.31M	$ 553.79M	$ 567.56M	$ 654.28M	$ 533.12M
Net Non Operating Interest Income Expense	$ ―	$ 26.34M	$ 6.49M	$ -12.29M	$ -16.15M	$ -11.34M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ 695.86M	$ 583.74M	$ 133.66M	$ 616.70M	$ 544.98M
Tax Provision	$ ―	$ 108.74M	$ 101.99M	$ 70.54M	$ 119.21M	$ 123.16M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ 590.17M	$ 498.79M	$ 79.82M	$ 465.35M	$ 396.24M
Basic EPS	$ ―	$ 0.74	$ 0.61	$ 0.09	$ 0.54	$ 0.46
Diluted EPS	$ ―	$ 0.73	$ 0.61	$ 0.09	$ 0.53	$ 0.46
Basic Average Shares	$ ―	$ 801.58M	$ 817.26M	$ 848.77M	$ 854.84M	$ 861.07M
Diluted Average Shares	$ ―	$ 804.70M	$ 817.26M	$ 854.47M	$ 877.99M	$ 867.11M
Dividend Per Share	$ ―	$ 0.25	$ 0.16	$ 0.27	$ 0.08	$ 0.12
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 1.39B	$ 1.20B	$ 1.16B	$ 1.19B	$ 1.13B
Net Income From Continuing And Discontinued Operation	$ ―	$ 590.17M	$ 498.79M	$ 79.82M	$ 465.35M	$ 396.24M
Normalized Income	$ ―	$ 591.85M	$ 498.99M	$ 703.57M	$ 465.54M	$ 396.48M
Interest Expense	$ ―	$ 12.90M	$ 21.40M	$ 29.04M	$ 22.53M	$ 11.05M
EBIT	$ ―	$ 708.77M	$ 605.14M	$ 162.71M	$ 639.23M	$ 556.03M
EBITDA	$ ―	$ 781.75M	$ 676.93M	$ 235.82M	$ 710.74M	$ 623.17M

Currency in USD

Consun Pharmaceutical Group Ltd. Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing